Where can I buy ANI Pharmaceuticals'stock?
Shares of ANIP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ANI Pharmaceuticals' stock price today?
What is Anani pharmaceuticals (ANIP) stock price based on earnings?
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) announced its quarterly earnings data on Sunday, October, 31st. The specialty pharmaceutical company reported $1.01 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.70 by $0.31.
How many shares of stock did Ani sell in its offering?
A total of 1,500,000 shares of its common stock were sold at a public offering price of $50.00 per share. The gross proceeds of the offering to the Company are $75 million, before deducting the underwriting discounts and commissions and offering expenses. In addition, ANI granted the underwriters a 30-day option to
Who owns Antani Pharmaceuticals'stock?
ANI Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (2. 73%), Global Alpha Capital Management Ltd. (2. 00%), Thompson Siegel & Walmsley LLC (1. 96%), Geode Capital Management LLC (1. 43%), Northern Trust Corp.
What does ANI Pharmaceuticals make?
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription pharmaceuticals. ANI Pharmaceuticals manufactures oral solid dose products, as well as liquid and topical products in the State of Minnesota.
Where is Ani pharmaceuticals manufactured?
Baudette, MinnesotaOur two pharmaceutical manufacturing facilities located in Baudette, Minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment.
Should I buy or sell ANI Pharmaceuticals stock right now?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ANI Pharmaceuticals in the last twelve months. There are currently 1 hold...
What is ANI Pharmaceuticals' stock price forecast for 2022?
3 analysts have issued 1-year target prices for ANI Pharmaceuticals' stock. Their forecasts range from $47.00 to $70.00. On average, they predict A...
How has ANI Pharmaceuticals' stock performed in 2022?
ANI Pharmaceuticals' stock was trading at $46.08 on January 1st, 2022. Since then, ANIP stock has decreased by 40.4% and is now trading at $27.48....
When is ANI Pharmaceuticals' next earnings date?
ANI Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022. View our earnings forecast for AN...
How were ANI Pharmaceuticals' earnings last quarter?
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) posted its earnings results on Tuesday, May, 10th. The specialty pharmaceutical company reported ($0.27) EP...
What guidance has ANI Pharmaceuticals issued on next quarter's earnings?
ANI Pharmaceuticals issued an update on its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided EPS guidance of $1.34-$1.62 for t...
Who are ANI Pharmaceuticals' key executives?
ANI Pharmaceuticals' management team includes the following people: Mr. Nikhil Lalwani , Pres, CEO & Director (Age 44, Pay $2.17M) Mr. Stephen P...
What is Arthur Przbyl's approval rating as ANI Pharmaceuticals' CEO?
1 employees have rated ANI Pharmaceuticals CEO Arthur Przbyl on Glassdoor.com . Arthur Przbyl has an approval rating of 100% among ANI Pharmaceuti...
Who are some of ANI Pharmaceuticals' key competitors?
Some companies that are related to ANI Pharmaceuticals include Schrödinger (SDGR) , Ironwood Pharmaceuticals (IRWD) , ChemoCentryx (CCXI) , OPK...
About ANI Pharmaceuticals
ANI Pharmaceuticals (NASDAQ:ANIP) Frequently Asked Questions
ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products.
Nasdaq Global Market
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ANI Pharmaceuticals in the last twelve months. There are currently 2 buy ratings for the stock.
Environmental, Social, and Governance Rating
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
Transparency is our policy. Learn how it impacts everything we do
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
RECENT NEWS
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
NASDAQ - ANIP
ANI Pharmaceuticals Announces Commercial Availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) for Multiple Chronic Autoimmune Disorders 01/24/2022
Premium Research for ANIP
Please see Indications and Important Safety Information and full Prescribing Information at Cortrophin.com .
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
